Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
May, M; Surcel, C; Capitanio, U; Dell'Oglio, P; Klatte, T; Shariat, S; Ecke, T; Wolff, I; Vergho, D; Wagener, N; Huck, N; Pahernik, S; Zastrow, S; Wirth, M; Borgmann, H; Haferkamp, A; Musquera, M; Krabbe, LM; Herrmann, E; Scavuzzo, A; Mirvald, C; Hutterer, G; Zigeuner, R; Stief, CG; Waidelich, R; Cindolo, L; Kalusova, K; Brookman-May, SD; Collaborative Research On Renal Neoplasms Association (CORONA) and European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group.
Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project).
Scand J Urol. 2017; 51(4):269-276
Doi: 10.1080/21681805.2017.1300187
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Hutterer Georg
- Zigeuner Richard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Studies on the prognostic reliability of the Union for International Cancer Control tumor, node, metastasis (TNM) staging system for renal cell carcinoma (RCC) predominantly focus on clear-cell RCC. Therefore, the aim of this study was to investigate whether the oncological prognosis of surgically treated papillary RCC (papRCC) patients is reliably given by the current TNM system, by analyzing the largest database reported to date. Data on 2325 papRCC patients who underwent surgical treatment in 1984- 2015 were collated from 17 international centers (median follow-up 47 months). Tumor stage was adapted to the 7th edition of the TNM system. Multivariable, bootstrap-corrected Cox regression models were applied to assess the independent impact of the TNM system on cancer-specific mortality (CSM) and all-cause mortality (ACM). The median age at diagnosis was 63 years (interquartile range 54-70 years) and 77% of patients were male. Nephron-sparing surgery was performed in 42%, and 82% were with symptom free at diagnosis. In 6.7% (n = 156), organ metastasis (stage M1) was present at the time of surgery. On multivariable analysis, the TNM system and Fuhrman grade had an independent impact on both CSM and ACM, while patient age affected ACM only. The discriminative ability of the pT classification was significant for both endpoints: 5 year CSM rates were 5%, 17%, 36% and 56% for stages pT1, pT2, pT3 and pT4, respectively (each p < 0.001). The pT classification contributed significantly to the predictive accuracy of the CSM and ACM models by 6.3% and 2.5%, respectively (each p < 0.001). The 2010 TNM staging system can be reliably applied to papRCC patients and allows certain prognostic discrimination.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Adult -
- Aged -
- Aged, 80 and over -
- Carcinoma, Renal Cell - mortality
- Carcinoma, Renal Cell - pathology
- Carcinoma, Renal Cell - surgery
- Female -
- Humans -
- Kidney Neoplasms - mortality
- Kidney Neoplasms - pathology
- Kidney Neoplasms - surgery
- Male -
- Middle Aged -
- Neoplasm Grading -
- Neoplasm Staging -
- Prognosis -
- Proportional Hazards Models -
- Young Adult -
- Find related publications in this database (Keywords)
- Papillary renal cell carcinoma
- predictive accuracy
- prognostic discrimination
- surgical treatment
- UICC TNM system 2010